GlaxoSmithKline's Shingrix Approved in the U.S. for Prevention of Shingles in Adults Aged 50 and … Post author:Sam Post published:October 22, 2017 Post category:BioPharma Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses. Source: BioSpace You Might Also Like Voyager Therapeutic's Parkinson's Trial Shows Positive Results March 8, 2018 <b>University Of Denver</b> Libraries Select <b>Yewno</b> Discover Research Application May 18, 2017 University at Albany Release: Biochemist's Technique Rapidly Detects Ebola Virus February 16, 2017
